MedPath

Effects of synbiotics in infants with atopic dermatitis

Completed
Conditions
Atopic Eczema Dermatitis Syndrome (AEDS)
Skin and Connective Tissue Diseases
Atopic dermatitis
Registration Number
ISRCTN69085979
Lead Sponsor
umico Research B.V. (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
90
Inclusion Criteria

1. Infants, between 0 and 7 months of age
2. Fulfilling standard criteria for AEDS

Exclusion Criteria

1. Scorad score 15
2. Use of anti-histamines or systemic corticosteroids or anti-mycotic drugs
3. Skin disorder other than AEDS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in Scorad score after 12 weeks of treatment is more than 25% greater in the active group compared to the placebo group.
Secondary Outcome Measures
NameTimeMethod
1. Immunological parameters<br>2. Faecal microbiota parameters<br>3. Quality of life of the parents and parental stress<br>4. Gastro-intestinal tract characteristics
© Copyright 2025. All Rights Reserved by MedPath